Evaluation of Elecsys HTLV‐I/II assay in comparison with ARCHITECT rHTLV‐I/II assay with Korean samples

BACKGROUND: The seroprevalence rate of human T‐lymphotropic virus I and II (HTLV‐I/II) in Korean blood donors has been known as 0.004%, and HTLV‐I/II Ab screening test has been performed since 2008 in Korea. Korea Ministry of Food and Drug Safety (MFDS) approved two chemiluminescent microparticle im...

Descripción completa

Detalles Bibliográficos
Autores principales: Yun, Seung Gyu, Kim, Sang‐wook, Sohn, Ji Yeon, Cho, Yunjung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642323/
https://www.ncbi.nlm.nih.gov/pubmed/31059152
http://dx.doi.org/10.1002/jcla.22909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642323/
https://www.ncbi.nlm.nih.gov/pubmed/31059152
http://dx.doi.org/10.1002/jcla.22909

Ejemplares similares